We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.33B
AUM Growth
+$61.2M
Cap. Flow
-$25.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
40.86%
Holding
462
New
13
Increased
102
Reduced
197
Closed
27

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$94.7M
2
NSC icon
Norfolk Southern
NSC
+$11M
3
ABT icon
Abbott
ABT
+$5.85M
4
FOUR icon
Shift4
FOUR
+$5.03M
5
CTO
CTO Realty Growth
CTO
+$4.73M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$103M
2
BMY icon
Bristol-Myers Squibb
BMY
+$12.3M
3
BABA icon
Alibaba
BABA
+$5.02M
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$3.73M
5
INTC icon
Intel
INTC
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 20.87%
2 Technology 15.71%
3 Energy 15.27%
4 Financials 12.65%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
26
Goldman Sachs
GS
$313B
$20.7M 0.89%
45,865
-1,684
-4% -$739K
UL icon
27
Unilever
UL
$131B
$20.2M 0.87%
326,223
-5,815
-2% -$344K
TMUS icon
28
T-Mobile US
TMUS
$193B
$19M 0.82%
107,990
+1,078
+1% +$181K
RTX icon
29
RTX Corp
RTX
$287B
$18.9M 0.81%
188,180
-852
-0.5% -$88.1K
C icon
30
Citigroup
C
$222B
$18.7M 0.81%
295,427
-1,553
-0.5% -$95.8K
OMER icon
31
Omeros
OMER
$709M
$18.6M 0.8%
4,593,148
-104,992
-2% -$375K
CPRT icon
32
Copart
CPRT
$25.9B
$18.6M 0.8%
344,156
-8,025
-2% -$438K
CB icon
33
Chubb
CB
$140B
$18.6M 0.8%
72,771
+766
+1% +$197K
PFE icon
34
Pfizer
PFE
$140B
$17.4M 0.75%
621,834
-1,098
-0.2% -$30.2K
CACC icon
35
Credit Acceptance
CACC
$6B
$16.9M 0.73%
32,916
-167
-0.5% -$85.1K
EXPE icon
36
Expedia Group
EXPE
$31.2B
$14.2M 0.61%
112,675
-110
-0.1% -$13.6K
EBAY icon
37
eBay
EBAY
$48.6B
$14.2M 0.61%
264,133
-7,484
-3% -$390K
GL icon
38
Globe Life
GL
$13.5B
$13.6M 0.58%
164,806
– –
JNJ icon
39
Johnson & Johnson
JNJ
$635B
$13.5M 0.58%
92,162
-1,895
-2% -$282K
FCX icon
40
Freeport-McMoran
FCX
$90B
$12.5M 0.54%
257,906
+6,980
+3% +$352K
KVUE icon
41
Kenvue
KVUE
$37B
$12.4M 0.54%
684,517
-7,562
-1% -$147K
NVS icon
42
Novartis
NVS
$295B
$12.2M 0.52%
114,225
+1,960
+2% +$197K
UNP icon
43
Union Pacific
UNP
$183B
$11.9M 0.51%
52,553
-984
-2% -$231K
BAC icon
44
Bank of America
BAC
$435B
$11.5M 0.49%
288,853
-29,882
-9% -$1.15M
PEP icon
45
PepsiCo
PEP
$186B
$11.5M 0.49%
69,570
-1,214
-2% -$210K
OXY icon
46
Occidental Petroleum
OXY
$57B
$11.2M 0.48%
177,532
+2
+0% +$128
NSC icon
47
Norfolk Southern
NSC
$78.8B
$10.9M 0.47%
50,930
+47,621
+1,439% +$11M
JCI icon
48
Johnson Controls International
JCI
$87.5B
$10.5M 0.45%
157,855
-12,579
-7% -$847K
DD icon
49
DuPont de Nemours
DD
$18.6B
$9.75M 0.42%
96,481
-620
-0.6% -$60.7K
CVX icon
50
Chevron
CVX
$388B
$9.09M 0.39%
58,135
-1,487
-2% -$237K
1
2
3 4 5

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return

Ingalls & Snyder LLC's Q2 2024 Portfolio in Review

As of Q2 2024, Ingalls & Snyder LLC held 462 positions worth $2.33B, up 2.7% from $2.26B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ingalls & Snyder LLC's Q2 2024 filing shows 13 new, 102 increased, 197 reduced and 27 closed positions. Its largest new stake was Innospec: 28,596 shares worth $3.53M. The largest sale was Pioneer Natural Resource Co., an estimated $103M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Energy.

  • Ingalls & Snyder LLC's largest Q2 2024 buy was Innospec: 28,596 shares worth $3.53M.
  • Ingalls & Snyder LLC added most to ExxonMobil in Q2 2024, an estimated $94.7M increase.
  • Ingalls & Snyder LLC's biggest Q2 2024 reduction was Bristol-Myers Squibb, cutting an estimated $12.3M.
  • Ingalls & Snyder LLC fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $103M.
  • Ingalls & Snyder LLC's ten largest holdings make up 41% of its $2.33B portfolio in Q2 2024.
  • Ingalls & Snyder LLC opened 13 new positions and closed 27 in Q2 2024.
  • Ingalls & Snyder LLC's portfolio value rose 2.7% quarter-over-quarter to $2.33B.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2024, filed 31 Jul 2024.